Medical aesthetic products. Beiersdorf hails FY 2022 as ‘one of our most successful financial years in recent history’

THE WHAT? Beiersdorf has branded fiscal 2022 as ‘one of its most successful financial years in recent history’ despite the volatile market. Group sales rose 10.6 percent in organic terms to €8.8 billion and EBIT significantly improved to €1.2 billion.

THE DETAILS The Consumer Business unit recorded a double-digit rise in sales thanks to favorable exchange rates and structural effects, the manufacturer of Nivea said and additional input costs were offset by consistent pricing initiatives and strict cost management.

All regions and brands contributed to the division’s growth and Beiersdorf gained market share on every continent led by the Nivea brand and the Derma business. The regions Africa/Asia/Australia saw sales increase 10.2 percent while the Americas recorded an impressive rise of 23.2 percent. Additionally, there was also good sales growth in Europe (+5.0 percent) despite the ongoing war in Eastern Europe.

THE WHY? Vincent Warnery, CEO of Beiersdorf, reveals, “2022 was an excellent year for Beiersdorf with a remarkable result for both business segments, Consumer and tesa. For the first time in at least two decades, we delivered double-digit organic sales growth. Our major growth and profitability drivers were well balanced between the NIVEA business in Europe, the NIVEA business in the Emerging Markets, our Derma business, and our luxury business with La Prairie. I am pleased to announce that with Eucerin and Aquaphor, our Derma business achieved a major milestone three years earlier than planned with nominal sales revenue of more than one billion euros for the first time. 2022 was also a challenging year in many respects, which makes us particularly proud of this excellent outcome and the profitable growth we have achieved. Thanks to the consistent pursuit of our C.A.R.E.+ strategy and our very well-balanced business portfolio, we can press ahead into the future more securely and with confidence.”

Medical aesthetic products refer to a category of products used in the field of medical aesthetics, which combines medical practices with cosmetic procedures to improve the appearance of individuals. These products are typically used under the supervision of trained medical professionals such as dermatologists, plastic surgeons, or specialized nurses. They are distinct from over-the-counter cosmetics in that they often contain higher concentrations of active ingredients or require medical expertise for their application.

Examples of medical aesthetic products include:

• Dermal Fillers: Injectable substances used to restore volume, fill wrinkles, and enhance facial contours. These may include hyaluronic acid fillers like Juvederm or collagen-stimulating fillers like Sculptra.

• Botulinum Toxin (Botox): Injectable neurotoxins used to temporarily paralyze facial muscles, reducing the appearance of wrinkles and fine lines caused by facial expressions.

• Chemical Peels: Solutions containing chemical exfoliants like glycolic acid, salicylic acid, or trichloroacetic acid, used to improve skin texture, treat acne scars, and reduce hyperpigmentation.

• Laser and Light Devices: Equipment used for various skin treatments, including hair removal, skin resurfacing, tattoo removal, and treatment of vascular and pigmented lesions.

• Prescription Skincare Products: Formulations containing active ingredients such as retinoids (e.g., tretinoin), hydroquinone, or prescription-strength antioxidants, designed to address specific dermatological concerns under medical supervision.

• Microneedling Devices: Devices that create tiny punctures in the skin to stimulate collagen production and improve skin texture and elasticity.

• Cosmeceuticals: High-quality skincare products that bridge the gap between cosmetics and pharmaceuticals, often containing biologically active ingredients with proven efficacy.